These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21958343)

  • 1. A risk-analysis approach to the evaluation of analytical quality.
    Ceriotti F; Cappelletti P; Caputo M; Di Serio F; Messeri G; Ottomano C; Plebani M; Soffiati G
    Clin Chem Lab Med; 2011 Oct; 50(1):67-71. PubMed ID: 21958343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma metrics used to assess analytical quality of clinical chemistry assays: importance of the allowable total error (TEa) target.
    Hens K; Berth M; Armbruster D; Westgard S
    Clin Chem Lab Med; 2014 Jul; 52(7):973-80. PubMed ID: 24615486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady state errors and risk of a QC strategy.
    Mackay MA; Badrick TC
    Clin Biochem; 2019 Feb; 64():37-43. PubMed ID: 30552866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the results from two different External Quality Assessment Schemes supports the utility of robust quality specifications.
    Carobene A; Franzini C; Ceriotti F
    Clin Chem Lab Med; 2011 Jul; 49(7):1143-9. PubMed ID: 21574887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory precision performance: state of the art versus operating specifications that assure the analytical quality required by clinical laboratory improvement amendments proficiency testing.
    Westgard JO; Bawa N; Ross JW; Lawson NS
    Arch Pathol Lab Med; 1996 Jul; 120(7):621-5. PubMed ID: 8757464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of analytical quality specifications based on biological within- and between-subject variation.
    Petersen PH; Fraser CG; Jørgensen L; Brandslund I; Stahl M; Gowans E; Libeer JC; Ricós C
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):543-50. PubMed ID: 12564835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art.
    Haeckel R; Wosniok W
    Clin Chem Lab Med; 2011 Apr; 49(4):623-35. PubMed ID: 21345158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical quality specifications for common reference intervals.
    Ricós C; Doménech MV; Perich C
    Clin Chem Lab Med; 2004; 42(7):858-62. PubMed ID: 15327023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assuring analytical quality through process planning and quality control.
    Westgard JO
    Arch Pathol Lab Med; 1992 Jul; 116(7):765-9. PubMed ID: 1497451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical performance specifications: relating laboratory performance to quality required for intended clinical use.
    Dalenberg DA; Schryver PG; Klee GG
    Clin Lab Med; 2013 Mar; 33(1):55-73. PubMed ID: 23331729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of a generally applicable model for the evaluation of uncertainty of measurement in clinical chemistry.
    Kristiansen J
    Clin Chem Lab Med; 2001 Oct; 39(10):920-31. PubMed ID: 11758604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits".
    Hyltoft Petersen P; Klee GG
    Clin Chim Acta; 2014 May; 432():127-34. PubMed ID: 24747109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the analytical performance of the Beckman Coulter AU680 automated analytical system based on quality specifications for allowable performance derived from biological variation.
    Cattozzo G; Albeni C; Calonaci A; De Luca G
    Clin Chem Lab Med; 2011 Sep; 49(9):1563-7. PubMed ID: 21663572
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of uncertainty measurement - A prerequisite of ISO1589 accreditation for clinical laboratories.
    Iqbal S; Ijaz A; Sharafat S
    J Pak Med Assoc; 2017 May; 67(5):701-705. PubMed ID: 28507355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple matrix of analytical performance to identify assays that risk patients using External Quality Assurance Program data.
    Mackay M; Hegedus G; Badrick T
    Clin Biochem; 2016 May; 49(7-8):596-600. PubMed ID: 26800780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality indicators and specifications for the extra-analytical phases in clinical laboratory management.
    Ricós C; García-Victoria M; de la Fuente B
    Clin Chem Lab Med; 2004; 42(6):578-82. PubMed ID: 15259371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining acceptable limits for the metrological traceability of specific measurands.
    Bais R; Armbruster D; Jansen RT; Klee G; Panteghini M; Passarelli J; Sikaris KA;
    Clin Chem Lab Med; 2013 May; 51(5):973-9. PubMed ID: 23525873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P; Haverkate F; Kluft C
    Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical quality goals derived from the total deviation from patients' homeostatic set points, with a margin for analytical errors.
    Bolann BJ; Asberg A
    Scand J Clin Lab Invest; 2004; 64(5):443-50. PubMed ID: 15276908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for improving quality in the measurement of bone markers.
    Bernardi D; Zaninotto M; Plebani M
    Clin Chim Acta; 2004 Aug; 346(1):79-86. PubMed ID: 15234639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.